Heart attack care unequal for women than men
Tuesday, 9 January 2018
LONDON, Jan 08 (BBC): Fewer women who suffer a heart attack would die if they were given the same treatments as men, a new study found.
Researchers analysed the outcomes of 180,368 Swedish patients who suffered a heart attack over a 10-year period.
Women were two times more likely to die from a type of heart attack than men in the year after having one.
The British Heart Foundation said: "Heart attacks are often seen as a male health issue, but more women die from heart disease than breast cancer."
Researchers at the University of Leeds and the Karolinska Institute in Sweden analysed data from Sweden's online cardiac registry.
They found women were on average less likely than men to receive the recommended treatments after a heart attack.
Prof Chris Gale, of the University of Leeds, who co-authored the study, said this is because: "There's misconception amongst the general public and healthcare professionals about what heart attack patients are like.
"Typically, when we think of a heart attack patient, we see a middle-aged man who is overweight, has diabetes and smokes.
"This is not always the case; heart attacks affect the wider spectrum of the population - including women."
In one specific heart condition, women were 34 per cent less likely to receive procedures which clear blocked arteries, such as bypass surgery and stents.
They were also 24 per cent less likely to be prescribed statin medication, which helps to prevent a second heart attack, and 16 per cent less likely to be given aspirin, which helps to prevent blood clots.
This is despite guidelines suggesting all three treatments should be given to both genders.
The study found that when women did receive all the recommended treatments, the gap in mortality between the sexes decreased in almost all circumstances.
Roughly 124,000 men and 70,000 women are hospitalised for heart attacks in the UK per year.
Prof Gale said that from their very first point of contact with healthcare professionals, women are less likely to receive the same diagnostic tests, leading them to be 50 per cent more likely to be initially misdiagnosed.